100 related articles for article (PubMed ID: 31519587)
1. Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 Cells.
Hunakova L; Horvathova E; Gronesova P; Bobal P; Otevrel J; Brtko J
Anticancer Res; 2019 Sep; 39(9):4845-4851. PubMed ID: 31519587
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells.
Hunakova L; Horvathova E; Majerova K; Bobal P; Otevrel J; Brtko J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857277
[TBL] [Abstract][Full Text] [Related]
3. Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231.
Hunakova L; Brtko J
Toxicol Lett; 2017 Sep; 279():16-21. PubMed ID: 28709983
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach.
Strouhalova D; Macejova D; Mosna B; Bobal P; Otevrel J; Lastovickova M; Brtko J; Bobalova J
Toxicol Lett; 2020 Jan; 318():22-29. PubMed ID: 31634547
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of tributyltin chloride and triphenyltin chloride in human breast cancer cell lines MCF-7 and MDA-MB-231.
Hunakova L; Macejova D; Toporova L; Brtko J
Tumour Biol; 2016 May; 37(5):6701-8. PubMed ID: 26662104
[TBL] [Abstract][Full Text] [Related]
6. In vitro antiproliferative and cytotoxic activities of novel triphenyltin isoselenocyanate in human breast carcinoma cell lines MCF 7 and MDA-MB-231.
Hunakova L; Horvathova E; Matuskova M; Bobal P; Otevrel J; Brtko J
Med Oncol; 2022 May; 39(5):99. PubMed ID: 35599282
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1.
Yang M; Teng W; Qu Y; Wang H; Yuan Q
Breast Cancer Res Treat; 2016 Jul; 158(2):277-86. PubMed ID: 27377973
[TBL] [Abstract][Full Text] [Related]
8. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
[TBL] [Abstract][Full Text] [Related]
9. The Triple-negative Breast Cancer Cell Line MDA-MB 231 Is Specifically Inhibited by the Ionophore Salinomycin.
Hero T; Bühler H; Kouam PN; Priesch-Grzeszowiak B; Lateit T; Adamietz IA
Anticancer Res; 2019 Jun; 39(6):2821-2827. PubMed ID: 31177119
[TBL] [Abstract][Full Text] [Related]
10. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
11. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.
Simu S; Marcovici I; Dobrescu A; Malita D; Dehelean CA; Coricovac D; Olaru F; Draghici GA; Navolan D
Molecules; 2021 May; 26(9):. PubMed ID: 34066763
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells.
Torki S; Soltani A; Shirzad H; Esmaeil N; Ghatrehsamani M
Biomed Pharmacother; 2017 Aug; 92():39-45. PubMed ID: 28528184
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells.
Ravi M; Tentu S; Baskar G; Rohan Prasad S; Raghavan S; Jayaprakash P; Jeyakanthan J; Rayala SK; Venkatraman G
BMC Cancer; 2015 Oct; 15():768. PubMed ID: 26499490
[TBL] [Abstract][Full Text] [Related]
15. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
Tsai SC; Huang WW; Huang WC; Lu CC; Chiang JH; Peng SF; Chung JG; Lin YH; Hsu YM; Amagaya S; Yang JS
Int J Oncol; 2012 Dec; 41(6):2065-72. PubMed ID: 23008020
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of tributyltin chloride and triphenyltin chloride on cell proliferation, proapoptotic p53, Bax, and antiapoptotic Bcl-2 protein levels in human breast cancer MCF-7 cell line.
Fickova M; Macho L; Brtko J
Toxicol In Vitro; 2015 Jun; 29(4):727-31. PubMed ID: 25743928
[TBL] [Abstract][Full Text] [Related]
17. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
20. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133
Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V
BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
